Oncology Nursing News®

Register now to learn about a new option for relapsed or refractory follicular lymphoma

Breast Cancer

Nurses' Role in Cardiotoxicity in Cancer Survivors

Nurses' Role in Cardiotoxicity in Cancer Survivors

BY BRIELLE BENYON

Navigating Breast Cancer Care During a Pandemic

Navigating Breast Cancer Care During a Pandemic

BY CANCERCARE

FDA Advancements in HER2+ Breast Cancer

FDA Advancements in HER2+ Breast Cancer

HER2-targeted Therapy: Routes of Administration

HER2-targeted Therapy: Routes of Administration

BY STAFF

FDA Recommends Black-Box Warning on Breast Implants

FDA Recommends Black-Box Warning on Breast Implants

BY BETH FAND INCOLLINGO

Practical Management of Early Stage HER2+ Breast Cancer

Practical Management of Early Stage HER2+ Breast Cancer

BY STAFF

The Importance of Conversing About Toxicity in HER2+ Breast Cancer Treatment

The Importance of Conversing About Toxicity in HER2+ Breast Cancer Treatment

BY BRIELLE BENYON

Diarrhea Management in HER2+ Breast Cancer

Diarrhea Management in HER2+ Breast Cancer

BY PATRICIA JAKEL, MN, RN, AOCN

Atezolizumab Plus Paclitaxel in Breast Cancer: FDA Issues Safety, Efficacy Alert

Atezolizumab Plus Paclitaxel in Breast Cancer: FDA Issues Safety, Efficacy Alert

BY KRISTI ROSA

Oral Paclitaxel/Encequidar Granted Priority Review for Metastatic Breast Cancer Treatment

Oral Paclitaxel/Encequidar Granted Priority Review for Metastatic Breast Cancer Treatment

BY KRISTI ROSA

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.